Prosecution Insights
Last updated: October 04, 2026

Kemeny Healthcare Inc.

Technology area: Medical Devices & Mechanical Engineering

3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Kemeny Healthcare Inc. has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. All these actions are assigned to 1 distinct art unit, though they are distributed among 3 distinct examiners. This indicates a very specific technical focus for the current portfolio.

MARJAN SABOKTAKIN is identified as the busiest examiner with 1 pending action. Because each of the 3 distinct examiners holds exactly 1 action, the workload is perfectly distributed. The concentration in 1 distinct art unit suggests that prosecution strategies can be tailored to the specific practices of that single USPTO division within the medical device field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
2
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (33%)
Double-patenting + other2 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
2
Business / Other
67% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SABOKTAKIN, MARJAN 1 58.7% +14.3%
KOHUTKA, BROOKE NICOLE 1 37.5% +92.3%
LANDEEN, BROGAN RANE 1 28.6% -33.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18647324 SYSTEMS FOR PROMOTING SEXUAL WELL-BEING IN MALES KOHUTKA, BROOKE NICOLE —
18643163 SYSTEMS FOR PROMOTING SEXUAL WELL-BEING IN MALES LANDEEN, BROGAN RANE —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19430769 SYSTEM FOR TREATING PEYRONIES DISEASE SABOKTAKIN, MARJAN —
18647324 SYSTEMS FOR PROMOTING SEXUAL WELL-BEING IN MALES KOHUTKA, BROOKE NICOLE —

Top Art Units

Art UnitApps
3797 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19430769 SYSTEM FOR TREATING PEYRONIES DISEASE SABOKTAKIN, MARJAN 3797 §103§112DP Non-Final OA — Pending Dec 23, 2025
18647324 SYSTEMS FOR PROMOTING SEXUAL WELL-BEING IN MALES KOHUTKA, BROOKE NICOLE — §101§103§112 Non-Final OA — Pending Apr 26, 2024
18643163 SYSTEMS FOR PROMOTING SEXUAL WELL-BEING IN MALES LANDEEN, BROGAN RANE — §103DP Non-Final OA — Pending Apr 23, 2024

Managing Kemeny Healthcare Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month